- World rank, all time
- #15,752 of 42,892
- Rank in Switzerland
- #146 of 429
- Research works
- 134 ▼ 29% vs 2013–17
- Citations
- 4.6k 34.2 per fractional work
- Top-10% rate
- 15.6% record average 16.5%
- Open access
- 53% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 24.6×. Every wedge is a field page.
Who are the top researchers at Light Chain Bioscience (Switzerland)?
Ranked on the composite score, Marie Kosco‐Vilbois, Walter Ferlin and Krzysztof Masternak lead among researchers whose main affiliation is Light Chain Bioscience (Switzerland).
- 1 Marie Kosco‐Vilbois Switzerland · #777,855 worldwide 60 citations · 25 works
- 2 Walter Ferlin Switzerland · #1,216,619 worldwide 45 citations · 19 works
- 3 Krzysztof Masternak Switzerland · #1,327,505 worldwide 55 citations · 24 works
- 4 Giovanni Magistrelli Switzerland · #1,512,746 worldwide 41 citations · 18 works
- 5 Nicolas Fischer Switzerland · #1,527,218 worldwide 15 citations · 27 works
- 6 Zoë Johnson Switzerland · #1,546,574 worldwide 10 citations · 17 works
- 7 Limin Shang Switzerland · #1,599,453 worldwide 15 citations · 18 works
- 8 Bruno Daubeuf Switzerland · #1,614,197 worldwide 7 citations · 20 works
- 9 Pauline Malinge Switzerland · #1,623,598 worldwide 12 citations · 16 works
- 10 Valéry Moine Switzerland · #1,629,697 worldwide 6 citations · 17 works
Which keywords describe research at Light Chain Bioscience (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer Immunotherapy, Cancer and Inflammation.
- Stability
- Protein Aggregation
- Neurodegeneration
- Recombinant Proteins
- Foxp3
- TGF-ß
- NK Cell Recognition
- Biopharmaceuticals
- apoptotic cells
- Tumor Antigen
- Phagocytosis
- Dendritic Cells
- Autoimmunity
- Mucins
- Therapeutics
- Immunity
- Cancer
- Inflammation
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Cancer Immunotherapy
- Innate Immunity
- Immune System
- Glycans
- Immune Regulation
- Antigen Presentation
- Macrophages
- CD47
- Vaccine Adjuvants
- Angiogenesis
- Immunotherapy
- Natural Killer Cells
- CD4+CD25+
- Tumor Targeting
- Immunogenicity
- Toll-like Receptors
- Chromatography
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation31▲ 104×3 topics
- Monoclonal Antibodies24▲ 123×3 topics
- Therapeutic Antibodies23▲ 133×2 topics
- Antibody Engineering18▲ 138×1 topic
- Fc Receptors18▲ 138×1 topic
- Inflammation18▲ 5.6×27 topics
- Cancer Immunotherapy17▲ 91×3 topics
- Cancer16▲ 8.5×16 topics
- Innate Immunity11▲ 24×8 topics
- Immunity10▲ 21×6 topics
- Immune System9▲ 21×3 topics
- Therapeutics9▲ 48×2 topics
- Glycans9▲ 83×1 topic
- Mucins9▲ 83×1 topic
- Immune Regulation9▲ 49×3 topics
- Autoimmunity8▲ 29×4 topics
- Antigen Presentation8▲ 57×2 topics
- Dendritic Cells8▲ 50×2 topics
- Macrophages8▲ 34×3 topics
- Phagocytosis8▲ 167×2 topics
- CD477▲ 361×1 topic
- Tumor Antigen7▲ 67×1 topic
- Vaccine Adjuvants7▲ 67×1 topic
- apoptotic cells7▲ 361×1 topic
- Angiogenesis6▲ 11×6 topics
- Biopharmaceuticals6▲ 64×3 topics
- Immunotherapy6▲ 6.8×6 topics
- NK Cell Recognition6▲ 43×1 topic
- Natural Killer Cells6▲ 43×1 topic
- TGF-ß6▲ 25×2 topics
- CD4+CD25+6▲ 57×1 topic
- Foxp36▲ 57×1 topic
- Tumor Targeting6▲ 31×3 topics
- Recombinant Proteins5▲ 73×2 topics
- Immunogenicity5▲ 74×2 topics
- Neurodegeneration5▲ 12×6 topics
- Toll-like Receptors5▲ 22×4 topics
- Protein Aggregation5▲ 45×2 topics
- Chromatography4▲ 115×1 topic
- Stability4▲ 17×1 topic
Which research topics does Light Chain Bioscience (Switzerland) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Phagocytosis and Immune Regulation and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
- 2 Glycosylation and Glycoproteins Research Molecular Biology 2 works
- 3 Phagocytosis and Immune Regulation Immunology 1 works
- 4 Immunotherapy and Immune Responses Immunology 1 works
- 5 CAR-T cell therapy research Oncology 1 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
- 8 Alzheimer's disease research and treatments Physiology 1 works
- 9 Nanoparticle-Based Drug Delivery Biomaterials 0 works
- 10 Galectins and Cancer Biology Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Light Chain Bioscience (Switzerland)'s research output changed?
Output in 2018–2022 was 29% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Geneva
- University of Geneva
- European Organization for Nuclear Research
- University Hospital of Geneva
- World Health Organization
- Hôpital Beau-Séjour
- Graduate Institute of International and Development Studies
- HES-SO Genève
- Clayton Foundation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.